The effect of dexketoprofen trometamol on postoperative analgesia and morphine consumption in major gynecologic surgery

Volume: 52 Number: 1 March 1, 2013
  • Karaman S
  • Günüşen İ
  • Ceylan A
  • Eyigör C
  • Sargın A
EN TR

The effect of dexketoprofen trometamol on postoperative analgesia and morphine consumption in major gynecologic surgery

Abstract

Aim: The use of opioids and non-steroidal anti-inflammatory drugs in combination for postoperative pain is common. In this randomized, double-blind, placebo-controlled study, we aimed to evaluate the analgesic efficacy, the effects on opioid consumption and postoperative side effect of intravenous dexketoprofen trometamol, in comparison with a placebo, in patients undergoing major gynecologic surgery. Materials and Methods: This study was performed on 56 patients (ASAI-II) planned for major gynecologic surgery. The patients who were randomly allocated into two equal groups received intravenous dexketoprofen trometamol 50 mg (Group I) or serum physiologic (Group II) 15-20 min before the end of surgery and at every 8 h for 24 h postoperatively. All patients received standard general anesthesia. Hemodynamic parameters, pain and sedation score, morphine consumption, side effects and patient satisfaction were recorded postoperatively. Results: Although the pain scores and total morphine consumption (Group I: 34.8±11.7 mg, Group II: 60.0±18.5 mg) in the dexketoprofen group was lower, the side effects were similar between the groups. The amount of morphine use at 2, 4, 6, 12 and 24 h was significantly lower in Group I, sedation scores at 2 and 12 h were higher in Group II. Conclusion: Dexketoprofen trometamol is associated with a decrease in morphine consumption and superior analgesic efficacy in major gynecologic surgery.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Karaman S

Günüşen İ

Ceylan A

Eyigör C

Sargın A

Publication Date

March 1, 2013

Submission Date

March 1, 2013

Acceptance Date

-

Published in Issue

Year 2013 Volume: 52 Number: 1

APA
S, K., İ, G., A, C., C, E., & A, S. (2013). Major jinekolojik cerrahide deksketoprofen trometamol’ün postoperatif analjezi ve morfin tüketimine etkisi. Ege Tıp Dergisi, 52(1), 1-6. https://izlik.org/JA48ZK47BS
AMA
1.S K, İ G, A C, C E, A S. Major jinekolojik cerrahide deksketoprofen trometamol’ün postoperatif analjezi ve morfin tüketimine etkisi. EJM. 2013;52(1):1-6. https://izlik.org/JA48ZK47BS
Chicago
S, Karaman, Günüşen İ, Ceylan A, Eyigör C, and Sargın A. 2013. “Major Jinekolojik Cerrahide Deksketoprofen Trometamol’ün Postoperatif Analjezi Ve Morfin Tüketimine Etkisi”. Ege Tıp Dergisi 52 (1): 1-6. https://izlik.org/JA48ZK47BS.
EndNote
S K, İ G, A C, C E, A S (March 1, 2013) Major jinekolojik cerrahide deksketoprofen trometamol’ün postoperatif analjezi ve morfin tüketimine etkisi. Ege Tıp Dergisi 52 1 1–6.
IEEE
[1]K. S, G. İ, C. A, E. C, and S. A, “Major jinekolojik cerrahide deksketoprofen trometamol’ün postoperatif analjezi ve morfin tüketimine etkisi”, EJM, vol. 52, no. 1, pp. 1–6, Mar. 2013, [Online]. Available: https://izlik.org/JA48ZK47BS
ISNAD
S, Karaman - İ, Günüşen - A, Ceylan - C, Eyigör - A, Sargın. “Major Jinekolojik Cerrahide Deksketoprofen Trometamol’ün Postoperatif Analjezi Ve Morfin Tüketimine Etkisi”. Ege Tıp Dergisi 52/1 (March 1, 2013): 1-6. https://izlik.org/JA48ZK47BS.
JAMA
1.S K, İ G, A C, C E, A S. Major jinekolojik cerrahide deksketoprofen trometamol’ün postoperatif analjezi ve morfin tüketimine etkisi. EJM. 2013;52:1–6.
MLA
S, Karaman, et al. “Major Jinekolojik Cerrahide Deksketoprofen Trometamol’ün Postoperatif Analjezi Ve Morfin Tüketimine Etkisi”. Ege Tıp Dergisi, vol. 52, no. 1, Mar. 2013, pp. 1-6, https://izlik.org/JA48ZK47BS.
Vancouver
1.Karaman S, Günüşen İ, Ceylan A, Eyigör C, Sargın A. Major jinekolojik cerrahide deksketoprofen trometamol’ün postoperatif analjezi ve morfin tüketimine etkisi. EJM [Internet]. 2013 Mar. 1;52(1):1-6. Available from: https://izlik.org/JA48ZK47BS

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.